NFGH
DAWN

Nan Fung Group Holdings’s Day One Biopharmaceuticals DAWN Stock Holding History

Nan Fung Group Holdings’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,445
Closed -$114K – 43
2022
Q1 		$114K Hold
11,445
– – 0.05% 42
2021
Q4 		$193K Buy
+11,445
New +$235K 0.06% 48

Other funds holding DAWN

CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nan Fung Group Holdings's DAWN Position: Q2 2022 in Review

Nan Fung Group Holdings sold out of Day One Biopharmaceuticals (DAWN) in Q2 2022, closing a stake of 11,445 shares — an estimated $114K sold.

Nan Fung Group Holdings first reported a position in DAWN in Q4 2021 and held it in 2 quarters. The position peaked at $193K in Q4 2021. 87 funds tracked by Wall St. Rank hold DAWN as of Q2 2022.

  • Nan Fung Group Holdings reported no remaining Day One Biopharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Nan Fung Group Holdings sold 11,445 Day One Biopharmaceuticals shares in Q2 2022, an estimated $114K.
  • Nan Fung Group Holdings first reported a position in Day One Biopharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Nan Fung Group Holdings's Day One Biopharmaceuticals position peaked at $193K in Q4 2021.
  • 87 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2022.

Based on Nan Fung Group Holdings's 13F filing for Q2 2022, filed 12 Aug 2022.